Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Astellas Pharma Inc.
Astellas Files Lawsuit against CV Therapeutics
March 21st, 2009
Astellas US Holding, Inc., a wholly owned subsidiary of Astellas Pharma Inc., announced that it has filed a lawsuit in the Delaware Chancery Court against CV Therapeutics Inc. (Nasdaq: CVTX) and its directors seeking, among other things, declaratory and injunctive relief to (i) prevent CV Therapeutics from applying its recently amended stockholders rights plan in a way that would prevent CV Therapeutics’ stockholders from tendering their shares into the tender offer announced by Astellas today and (ii) preclude CV Therapeutics from claiming that a 2000 agreement between Astellas and CV Therapeutics has been violated by the Astellas tender offer. Earlier today, Sturgeon...
Source: Law & Health Weekly (2009-03-21)
|
